跳至主要内容
临床试验/ISRCTN21363594
ISRCTN21363594已完成未知

A pilot randomized clinical trial of therapeutic plasma exchange (TPE) in serious SARS CoV-2 disease (COVID-19)

King Saud Medical City0 个研究点目标入组 87 人开始时间: 2020年5月18日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
87

研究概览

简要总结

2020 Protocol article in https://doi.org/10.1186/s13063-020-04454-4 protocol (added 10/06/2020) 2021 Results article in https://pubmed.ncbi.nlm.nih.gov/33838224/ (added 14/06/2023)

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged =18 years
  • 2. Admitted to ICU and intubated
  • 3. Serious COVID-19 as per World Health Organization and Saudi Centers for Disease Control and Prevention case definition. SARS-CoV-2 infection should be confirmed by real-time polymerase chain reaction (RT-PCR) assays
  • 4. At risk of cytokine release syndrome (CRS)

排除标准

  • 1. Previous allergic reaction to plasma exchange reagents (e.g. sodium citrate) or equipment
  • 2. Two consecutive negative RT-PCR tests for SARS-CoV-2 taken at least 24 h apart
  • 3. Mild COVID-19 cases not requiring ICU admission
  • 4. Terminally ill patients receiving palliative care

研究者

相似试验

Therapeutic plasma exchange (removal of the non-cell... | 临床试验